Author:
CHENG Lian Sheng,LIU Ai Ping,YANG Jia Hong,DONG Yan Qiu,LI Liang Wei,WANG Jing,WANG Chao Chen,LIU Jing
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Molecular Biology
Reference31 articles.
1. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL . Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987; 235:177–82.
2. Hung MC, Matin A, Zhang Y, et al. HER-2/neu-targeting gene therapy-a review. Gene 1995; 235:177–82.
3. Ravdin PM, Chamness GC . The c-erbB-2 proto-oncogene as a prognostic and predictive marker in breast cancer: a paradigm for the development of other macromolecular markers-a review. Gene 1995; 159:19–27.
4. Graus-Porta D, Beerli RR, Daly JM, Hynes NE . ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling. EMBO J 1997; 16:1647–55.
5. Busse D, Doughty RS, Arteaga CL . HER-2/neu (erbB-2) and the cell cycle. Semin Oncol 2000; 27:3–8.
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献